share_log

公告精选 | 重大调整!阿里巴巴设六大业务集团,或将独立上市;比​亚迪股份去年净利增逾四倍

Featured Announcements | Major Changes! Alibaba has set up six major business groups and may be listed independently; the net profit of BYD shares increased more than fourfold last year

Futu News ·  Mar 29, 2023 08:25

A selection of major announcements

1. Alibaba announced a new organizational and governance structure and plans to establish six major business groups

$BABA-SW (09988.HK)$A new organizational and governance structure was announced. According to this plan, Alibaba Group will have six major business groups and other investments, managed independently by their respective CEOs and boards of directors.

The six major business groups are: 1. Cloud Intelligence Group (including Cloud, AI, DingTalk, etc.), with Zhang Yong, Chairman and CEO of Alibaba Group as CEO; 2. Taobao Tmall Business Group (including businesses such as Taobao, Tmall, Taotte, TaocaiCai, 1688.com, etc.), with Dai Shan as CEO; 3. Local Life Group (including businesses such as Gaode, Hungry), with Yu Yongfu as CEO; 4. International Digital Business Group (including Lazada, AliExpress, Trendyol, Daraz, Daraz, etc.) Alibaba.com and other businesses), with Jiang Fan as CEO; 5. Cainiao Group, with Wan Lin as CEO; and 6. Big Entertainment Group (including businesses such as Youku and Alibaba Pictures), with Fan Luyuan as CEO.

In addition to the fact that Taobao Tmall Commercial Group will continue to be wholly owned by Alibaba Group in the future, each business group will have independent financing and seek the possibility of a separate listing.

2. The net profit of BYD shares in 2022 increased 445.86% year-on-year to 16.6 billion yuan. It is proposed to distribute 11.42 yuan per 10

$BYD COMPANY (01211.HK)$The 2022 annual report was released. The company's revenue was 424.061 billion yuan, an increase of 96.20% over the previous year. Net profit attributable to shareholders of listed companies was 16.622 billion yuan, an increase of 445.86% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 15.638 billion yuan, an increase of 1146.42% over the previous year. Basic earnings per share were $5.71. Furthermore, it is proposed to distribute a cash dividend of 11.42 yuan (tax included) for every 10 shares to all shareholders.

3. SMIC's net profit in 2022 exceeded 1.8 billion US dollars and reached a record high, and gross margin rose to 38%

$SMIC (00981.HK)$Announcing results for the year ending December 31, 2022, the group achieved revenue of 7.273 billion US dollars, an increase of 33.6% over the previous year; net profit attributable to shareholders of listed companies was 1,818 million US dollars, up 6.8% year on year; gross profit margin was 38%, up 7.2 percentage points year on year; and basic earnings per share of 0.23 US dollars. According to the announcement, the increase in revenue was mainly due to the increase in the number of wafers sold this year and the increase in the average selling price.

4. Shangtang-W: 2022 revenue of 3.808 billion yuan, down 19% from the same period

$SENSETIME-W (00020.HK)$The 2022 results were announced, with revenue of approximately RMB 3,808.5 billion (same unit), a decrease of 19% over the previous year; gross profit was approximately RMB 2,542 million, a decrease of 22.4% over the previous year, with a gross margin of 66.8%; and losses attributable to corporate equity holders were approximately RMB 6.045 billion, a decrease of 64.73% over the previous year.

5. Tencent Holdings spent HK$350 million to repurchase 940,000 shares on March 28

$TENCENT (00700.HK)$: On March 28, 940,000 shares were repurchased at a price of HK$366.8-379.2, at a total cost of about HK$350 million.

Financial data

Kerry Logistics (00636): Core net profit increased 11% to HK$3,572 million in 2022, final interest of HK38 cents

Celadon Games (6633) reversed mid-term losses in 2022 and recorded adjusted net profit of about 50.7 million for the whole year

The annual net profit of Goldland Commercial Real Estate (00535) fell 42% to 2,311 million yuan, with final interest of 0.007 yuan

The annual revenue of Elegant Life Services (03319) was 15.379 billion yuan, up 9.2% year-on-year

Ming Yuanyun (00909) announced results: revenue reached 1.82 billion yuan in 2022

Starry Sky Chinese (06698): Adjusted net profit of 121 million yuan in 2022

Huaxin Cement (06655): Net profit of 2,699 million yuan in 2022 fell 49.68% year-on-year

Shangtang-W (00020): Revenue in 2022 was 3.808.5 billion yuan, a decrease of 19% over the previous year; loss attributable to shareholders was 6,045 billion yuan, a decrease of 64.73% over the previous year.

BYD Electronics (00285) annual performance: revenue exceeded 107.1 billion yuan and reached a new high, and the NEV business activated a second growth curve

Huitongda Network (09878): Total revenue reached 80.35 billion yuan in 2022, up 22.2% year-on-year

Dongyue Group (00189)'s net profit of 3.856 billion yuan in 2022 increased 85.83% year-on-year

TV Broadcast (00511): Shareholders' attributable loss of HK$807 million in 2022

Medical sector:

China Resources Healthcare's (01515) annual net profit fell 66.75% to $139 million, final interest was 3.7 Hong Kong cents

Jingdong Health's (09886) annual adjusted net loss of 129 million yuan decreased 60.9% year-on-year

Deqi Pharmaceutical-B (6996): Product revenue reached 5.6 times to 160 million yuan in 2022

Cinda Biotech's (01801) revenue increased steadily to 4,556 billion yuan in 2022. R&D and commercialization in the non-oncology and oncology fields went hand in hand

Tiger Pharmaceuticals (03347): Adjusted net profit increased 5.1% to 1,666 million yuan in 2022, plans to distribute 5.5 yuan per 10

Financial sector:

China Cinda (01359): Net profit of 6.313 billion yuan in 2022 fell 47.7% year-on-year

Haitong International (00665): Core revenue of HK$3.33 billion decreased by 33.37% year-on-year in 2022

Food and beverage sector:

Nongfu Spring (09633): Net profit returned to mother increased 18.6% to 8.495 billion yuan in 2022, final interest of 0.68 yuan

Wanzhou International (00288): Profit attributable to company owners (before biofair value adjustment) rose 34.3% to US$1,401 million in 2022

China Feihe (06186) 2022 results release: revenue for the second half of the year bucked the trend and increased 20.3% month-on-month

Xiabuxiabu (00520): Net loss of 353 million yuan in 2022, proposed final interest of 0.028 yuan per share

Baiguoyuan Group (02411)'s net profit of 323 million yuan in 2022 increased 40.4% year-on-year

Blue Moon Group (06993) revenue in 2022 increased by about 7.7% year-on-year to RMB 6.785 billion

The first section with Chinese characters:

CIMC Group (02039)'s net profit fell 51.7% year-on-year to 3,219 million yuan last year, with final interest of 0.18 yuan per share

Net profit of Taiping, China (00966) reached HK$2,797 million in 2022

Sinopec Oil Service (01033): Net profit of 460 million yuan in 2022 increased 158% year-on-year

China Innovation Aviation (03931) announced annual results, net profit surged 393.9%, scale effects were significant, and gross margin increased rapidly

Energy and power sector:

The annual net profit of Jingneng Clean Energy (00579) increased by 12.57% to 2,847 million yuan with a final interest rate of 12.02 cents

The net profit of Datang New Energy (01798) in 2022 was 3.485 billion yuan, up 71.55% year-on-year

The annual revenue of Datang Power (00991) was about 116.828 billion yuan, up about 12.76% year-on-year

The profit attributable to shareholders of Kunlun Energy (00135) was 5.228 billion yuan, up 1.7% year-on-year

Investment and operation

Jiahe Biological-B (06998): The National Drug Administration accepts the marketing license application for a new drug called roxilihydrochloride tablets (GB491)

Conoah-B (02162): The phase III clinical trial of CM310 for the treatment of severe atopic dermatitis in adults reached the end of the main study

Kangzhe Pharmaceutical (00867): Kanglianda and Junshi Biotech set up a joint venture to cooperate in the development and commercialization of treplizumab in many Southeast Asian countries

Shanghai Pharmaceutical (02607): SPH4336 obtained US FDA's orphan drug qualification certification, and tadalafil tablets approved for production

Huitongda Network (09878): The Group's government procurement business can be paid through a third party

Yeju Medical (06929): Invest in R&D and production base for vascular interventional medical devices in Fuchun Bay New Town, Hangzhou

Repurchase cancellation

Tencent Holdings (00700) spent HK$353 million to repurchase 940,000 shares on March 28

AIA (01299) spent HK$132 million to repurchase 1,614,200 shares on March 28

Standard Chartered Group (02888) spent £1.184,400 to buy back 200,000 shares on March 27

First Time Holdings (00697) spent HK$25.7537 million to repurchase 13.54 million shares on March 28

Equity incentives

Zulong Entertainment (09990) granted 9.02 million restricted share units

Yongda Auto (03669) granted 5.66 million reward shares

Sihuan Pharmaceutical (00460): The trustee purchased 3 million shares in connection with the share incentive plan

Spin-off listing

China Southern Airlines Co., Ltd. (01055): Plans to spin-off its subsidiary China Southern Airlines Logistics and list it on the main board of the Shanghai Stock Exchange

edit/new

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment